Research Areas
In this section, by far, most Axon Ligands™ are categorized as research tools that find their application in cell signaling and oncology. Targeting a multitude of specific enzymes and receptors, they either stimulate or block particular cellular signaling pathways that are implicated in various kinds of cancer. Naturally, all products in this section can also be found by their specific biological targets as listed in the sections of enzymes, receptors, transcription factors, proteins and/or signaling pathways. Besides the comprehensive set of compounds that targe cell signaling and oncology, selections of Axon Ligands™ have also been made for other research area's such as cardiovascular diseases, angiogenisis, epigenetics, stem cell research, among many others.
| Axon ID | Name | Description | From price | |
|---|---|---|---|---|
| 1066 | N-Cyclopropyl-N-methyl-2-aminotetraline hydrobromide | MAO inhibitor | €95.00 | |
| 3144 | (+)-Blebbistatin | Negative control of (±)-Blebbistatin as an inhibitor of class II myosins | €90.00 | |
| 1989 | (+)-JQ-1 |
Potent and selective BET bromodomain inhibitor |
€70.00 | |
| 1730 | (+)-Kifunensine | α-mannosidase inhibitor | €120.00 | |
| 3074 | (-)-Blebbistatin | Selective inhibitor of class II myosins; Active enantiomer of (±)-Blebbistatin | €90.00 | |
| 1229 | (R)-(-)-Rolipram | PDE4 inhibitor | €110.00 | |
| 2830 | (R)-CE3F4 | Potent inhibitor of EPAC1 | €105.00 | |
| 1432 | (S)-(+)-Rolipram | PDE4 inhibitor | €115.00 | |
| 2296 | (S)-Crizotinib | MTH1 inhibitor | €85.00 | |
| 2718 | (±)-Blebbistatin | Potent and specific inhibitor of class II myosins | €95.00 | |
| 1687 | (±)-E-Homocamptothecin | Potent topoisomerase I (Topo 1) inhibitor | €120.00 | |
| 2786 | (±)-PH 797804 | Inhibitor of p38α MAPK | €115.00 | |
| 2537 | 1,5-Isoquinolinediol | PARP1 inhibitor and neuroprotective agent | €50.00 | |
| 2434 | 1-Deazaadenosine | Adenosine deaminase (ADA) inhibitor with cytostatic activity in vitro | €135.00 | |
| 1892 | 1-NM-PP1 | Potent tyrosine kinase inhibitor (TKI) of multiple targets (Src, Fyn, Abl, CDK, Trk) | €95.00 | |